Hans FliriÂ
 Chairman
Drug Discovery.
Cypralis
United Kingdom
Biography
Hans Fliri has more than 35 years’ experience in the healthcare sector having held senior management positions in global pharmaceutical and biotechnology companies. He held research and management positions at Sandoz (now Novartis) in Basel between 1977 and 1994, was Senior Director of anti-infective drug discovery and lead generation at Rhone-Poulenc Rorer and later Aventis in Paris (1994-2000) and Vice President of Drug Discovery at Cetek Corporation (2001-2002) in the US. He is a founder of Selcia Holdings Ltd and led the company through a management buy-out from Scynexis Europe in 2005. He holds a PhD in chemistry from the University of Innsbruck and is the author of approximately 50 scientific articles and patents. He is an acknowledged expert in macrocyclic chemistry and a leader in the field of PPIase drug discovery.
Research Interest
Drug Discovery